Darwin Advisors, LLC Merck & Co., Inc. Transaction History

Darwin Advisors, LLC

$356 Million
Q3 2024

A detailed history of Darwin Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Darwin Advisors, LLC holds 278 shares of MRK stock, worth $25,225. This represents 0.01% of its overall portfolio holdings.

Number of Shares

278

Holding current value

$25,225

% of portfolio

0.01%

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$111.15 - $128.97 $30,899 - $35,853	278 New	278 $31,000
Q4 2022 Jan 17, 2023	BUY	$87.44 - $112.11 $1.19 Million - $1.53 Million	13,624 New	13,624 $0
Q3 2021 Oct 27, 2021	SELL	$71.68 - $78.83 $234,752 - $258,168	-3,275 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$70.31 - $77.77 $36,772 - $40,673	523 Added 19.0%	3,275 $255,000
Q1 2021 May 17, 2021	BUY	$68.86 - $81.11 $3,167 - $3,731	46 Added 1.7%	2,752 $212,000
Q4 2020 Feb 16, 2021	SELL	$71.77 - $79.65 $16,004 - $17,761	-223 Reduced 7.61%	2,706 $221,000
Q3 2020 Oct 16, 2020	BUY	$73.18 - $82.95 $5,634 - $6,387	77 Added 2.7%	2,929 $243,000
Q2 2020 Aug 06, 2020	SELL	$70.42 - $80.13 $18,027 - $20,513	-256 Reduced 8.24%	2,852 $220,000
Q1 2020 May 01, 2020	BUY	$63.36 - $87.82 $196,922 - $272,944	3,108 New	3,108 $238,000

Others Institutions Holding MRK

# of Institutions

3,828

Shares Held

1.87B

Call Options Held

15.5M

Put Options Held

13.6M

Vanguard Group Inc Valley Forge, PA

250M
Shares

$22.7 Billion
0.52% of portfolio
Black Rock Inc. New York, NY

207M
Shares

$18.8 Billion
0.59% of portfolio
State Street Corp Boston, MA

119M
Shares

$10.8 Billion
0.56% of portfolio
Wellington Management Group LLP Boston, MA

75.8M
Shares

$6.88 Billion
1.55% of portfolio
Geode Capital Management, LLC Boston, MA

59.2M
Shares

$5.37 Billion
0.55% of portfolio

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $230B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Darwin Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Darwin Advisors, LLC with notifications on news.

Account